Cancer Family
Gastric Neoplasm
CI-CAN-00000185Explore in graph →
Non-malignant718 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000185Explore in graph →
Clinical trials
3,260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05671393 | the Optimal Surveillance Frequency for Patients With Gastric Neuroendocrine Carcinoma | completed | — | 801 | Fujian Medical UniversityOTHER | 1 | Jan 4, 2023 | clinicaltrials |
| NCT05663450 | Extended Resection After Positive Intraoperative Pathology in Gastric Cancer Surgery | completed | — | 679 | University Hospital of CologneOTHER | 0 | Dec 23, 2022 | clinicaltrials |
| NCT03817866 | Chromogranin A as Blood Marker in Cancer Patients | completed | — | 175 | Brahms AGINDUSTRY | 2 | Dec 20, 2022 | clinicaltrials |
| NCT02810652 | Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection | completed | N/A | 160 | Massachusetts General HospitalOTHER | 1 | Nov 22, 2022 | clinicaltrials |
| NCT05327231 | IN10018 Monotherapy or in Combination With Docetaxel in Gastric or GEJ Adenocarcinoma | completed | Phase 1 | 33 | InxMed (Shanghai) Co., Ltd.INDUSTRY | 1 | Nov 16, 2022 | clinicaltrials |
| NCT00911820 | Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer | completed | Phase 2 | 88 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 8, 2022 | clinicaltrials |
| NCT03368196 | DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Protein | completed | Phase 1 | 12 | Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo CompanyINDUSTRY | 1 | Nov 3, 2022 | clinicaltrials |
| NCT05604378 | Relationship of EBV-positive Gastric Cancer and Multiple Genes Associated With Gastric Carcinogenesis | completed | — | 460 | Saint Vincent's Hospital, KoreaOTHER | 1 | Nov 3, 2022 | clinicaltrials |
| NCT05266300 | Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines. | completed | — | 722 | University of Southern DenmarkOTHER | 1 | Nov 1, 2022 | clinicaltrials |
| NCT05585437 | Effect of Gastric Cancer Specialist Training Program in Laparoscopic Gastric Cancer Surgery（STP-LRG-1） | completed | — | 183 | Fujian Medical UniversityOTHER | 1 | Oct 18, 2022 | clinicaltrials |
| NCT02489422 | Programs To Support You During Chemotherapy(PRO-YOU) | completed | N/A | 44 | Wake Forest University Health SciencesOTHER | 1 | Oct 14, 2022 | clinicaltrials |
| NCT05334849 | Prospectively Predict the Immunotherapy Response of Gastric Cancer Based on Circulating Exosomal LncRNA-GC1 Biopsy | completed | — | 80 | Lin ChenOTHER | 1 | Oct 12, 2022 | clinicaltrials |
| NCT04047004 | Adjuvant PIPAC in Gastric Cancer Patients(PIPAC-OPC4) | completed | Phase 1 | 20 | Michael Bau MortensenOTHER | 2 | Oct 6, 2022 | clinicaltrials |
| NCT02310464 | Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects | completed | Phase 1 | 25 | OBI Pharma, IncINDUSTRY | 1 | Oct 3, 2022 | clinicaltrials |
| NCT03755440 | PD-1 Antibody in EBV Positive Metastatic Gastric Cancer Patients. | completed | Phase 2 | 6 | Sun Yat-sen UniversityOTHER | 1 | Sep 21, 2022 | clinicaltrials |
| NCT01212822 | Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer | completed | Phase 2 | 20 | Fox Chase Cancer CenterOTHER | 1 | Sep 7, 2022 | clinicaltrials |
| NCT01938326 | Pure Single Incision Laparoscopic Distal Gastrectomy (SIDG) Versus Totally Laparoscopic Distal Gastrectomy (TLDG) | completed | N/A | 86 | Seoul National University Bundang HospitalOTHER | 1 | Sep 6, 2022 | clinicaltrials |
| NCT03662204 | Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors | completed | — | 5,133 | Exact Sciences CorporationINDUSTRY | 1 | Sep 1, 2022 | clinicaltrials |
| NCT04483349 | Assessment of What Patients and Healthcare Providers Value | completed | — | 397 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 31, 2022 | clinicaltrials |
| NCT02725424 | Optimizing the Strategy for Preoperative Chemotherapy in Locally Advanced Gastric/Gastroesophageal Cancer(MATCH) | completed | Phase 2 | 180 | Chinese Academy of Medical SciencesOTHER | 1 | Aug 17, 2022 | clinicaltrials |
| NCT03485196 | The Relationship Between Microsatellite Instability and Efficacy of Fluorouracil Based Adjuvant Chemotherapy in Gastric Cancer After Operation | completed | — | 1,000 | Affiliated Hospital of Qinghai UniversityOTHER | 1 | Aug 10, 2022 | clinicaltrials |
| NCT03425058 | Molecular Evaluation of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer(MENCA-GC) | completed | — | 80 | Peking University Cancer Hospital & InstituteOTHER | 1 | Aug 9, 2022 | clinicaltrials |
| NCT04791293 | The Model for End-Stage Liver Disease Sodium (MELD-Na) Score in Non-cirrhotic Patients With Gastric Cancer | completed | — | 159 | Istanbul Training and Research HospitalOTHER_GOV | 1 | Aug 9, 2022 | clinicaltrials |
| NCT02335411 | A Study of Pembrolizumab (MK-3475) in Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-059/KEYNOTE-059) | completed | Phase 2 | 318 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Aug 8, 2022 | clinicaltrials |
| NCT03604653 | Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers | completed | — | 10 | Holy Name Medical Center, Inc.OTHER | 1 | Aug 3, 2022 | clinicaltrials |
| NCT04545632 | Docetaxel Ethanol-induced Symptoms; The Incidence and Risk Forecating Factor(DETECT) | completed | — | 458 | Boryung Pharmaceutical Co., LtdINDUSTRY | 1 | Jul 27, 2022 | clinicaltrials |
| NCT02711969 | A Study of Apatinib Mesylate (YN968D1) 1,000mg in Gastric Cancer Patient Failed to Standard Treatment | completed | Phase 1 | 6 | Bukwang PharmaceuticalINDUSTRY | 1 | Jul 22, 2022 | clinicaltrials |
| NCT04649372 | EndoVE endosCopic Treatment for Oesophageal and Gastric canceR(VECTOR) | completed | N/A | 30 | Mirai MedicalINDUSTRY | 1 | Jul 21, 2022 | clinicaltrials |
| NCT05465993 | the Optimal Surveillance Frequency for Stage II/III Gastric Cancer | completed | — | 2,311 | Fujian Medical UniversityOTHER | 1 | Jul 20, 2022 | clinicaltrials |
| NCT05465512 | Using Radiomics to Predict Neoadjuvant Chemotherapy Efficacy | completed | — | 193 | Fujian Medical UniversityOTHER | 1 | Jul 19, 2022 | clinicaltrials |
| NCT02661971 | FLOT vs. FLOT/Ramucirumab for Perioperative Therapy of Gastric or GEJ Cancer (RAMSES)(RAMSES/FLOT7) | completed | Phase 2 / Phase 3 | 180 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestOTHER | 2 | Jul 11, 2022 | clinicaltrials |
| NCT01854255 | Intraperitoneal Aerosol Chemotherapy in Gastric Cancer(PIPAC-GA01) | completed | Phase 2 | 35 | Ruhr University of BochumOTHER | 1 | Jul 8, 2022 | clinicaltrials |
| NCT03042611 | A Study to Evaluate Rivoceranib Plus Best Supportive Care Compared to Placebo Plus Best Supportive Care in Participants With Gastric Cancer(ANGEL) | completed | Phase 3 | 460 | Elevar TherapeuticsINDUSTRY | 12 | Jul 8, 2022 | clinicaltrials |
| NCT05442502 | Safety and Efficacy of OGT Method Versus the Traditional Overlap Method(OGT) | completed | — | 155 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Jul 5, 2022 | clinicaltrials |
| NCT05265221 | Learning Curve for Gastric Endoscopic Submucosal Dissection | completed | — | 356 | Soonchunhyang University HospitalOTHER | 1 | Jun 30, 2022 | clinicaltrials |
| NCT04529135 | The Effect of Dexmedetomidine During Opioid Free Anesthesia on Postoperative Recovery After Gastrectomy | completed | N/A | 68 | Gangnam Severance HospitalOTHER | 1 | Jun 23, 2022 | clinicaltrials |
| NCT02299648 | The Screening Protocol for The VIKTORY Trial | completed | N/A | 651 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT03170180 | Exploratory Study of Drug Sensitivity Prediction Software (IRCR-DReSS) With Patient-derived Tumor Cells of Metastatic Gastric Cancer | completed | Phase 2 | 66 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT02898077 | A Study of Paclitaxel With or Without Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Cancer | completed | Phase 3 | 440 | Eli Lilly and CompanyINDUSTRY | 4 | Jun 14, 2022 | clinicaltrials |
| NCT02370498 | A Study of Pembrolizumab (MK-3475) Versus Paclitaxel for Participants With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma That Progressed After Therapy With Platinum and Fluoropyrimidine (MK-3475-061/KEYNOTE-061) | completed | Phase 3 | 592 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jun 6, 2022 | clinicaltrials |
| NCT05301699 | Development and Validation of a Web-based Nomorgam to Predict Postoperative Complications | completed | — | 582 | Nanjing Medical UniversityOTHER | 1 | Jun 1, 2022 | clinicaltrials |
| NCT05397444 | Handgrip Strength (HGS) With HGS Asymmetry Are Associated With All-cause Mortality and Hospital Readmissions | completed | — | 342 | Nanjing Medical UniversityOTHER | 1 | May 31, 2022 | clinicaltrials |
| NCT03365791 | PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies | completed | Phase 2 | 76 | Novartis PharmaceuticalsINDUSTRY | 1 | May 27, 2022 | clinicaltrials |
| NCT03409848 | Ipilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric Adenocarcinoma(INTEGA) | completed | Phase 2 | 97 | AIO-Studien-gGmbHOTHER | 1 | May 18, 2022 | clinicaltrials |
| NCT05219539 | Questionnaire Survey of the Advanced Training Program for Laparoscopic Radical Gastrectomy(ATP-LRG-1) | completed | — | 1,355 | Fujian Medical UniversityOTHER | 1 | May 10, 2022 | clinicaltrials |
| NCT04088786 | Phase I Trial HIPEC With Nal-irinotecan | completed | Phase 1 | 18 | Stony Brook UniversityOTHER | 1 | May 6, 2022 | clinicaltrials |
| NCT01711242 | Trial of Adjuvant XELOX Chemotherapy and Concurrent Capecitabine and Radiotherapy for Resected Gastric Carcinoma | completed | Phase 2 | 208 | xie congyingOTHER | 1 | May 5, 2022 | clinicaltrials |
| NCT04316078 | A Novel Patient Engagement Platform Among Patients With Gastrointestinal Malignancies | completed | N/A | 126 | Sheba Medical CenterOTHER_GOV | 1 | Apr 28, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Jan 4, 2023source: clinicaltrials